Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Timothy Goggins"'
Autor:
John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew S Paulson, Joleen M Hubbard, Andrew L Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon M Kasi, Heinz-Josef Lenz, Kristen K Ciombor, Elena Elez, David L Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios S Bekaii-Saab, Marc Peeters, Marc Van den Evnde, Christophe Borg, Matthieu Sarabi, Francois Ghiringhelli, Benoist Chibaudel, Maria G. Zampino, Susana R. Keranen, Ramon Salazar, Pilar Alfonso, John H. Strickler, Andrew S. Paulson, Joleen M. Hubbard, Andrew L. Coveler, Pashtoon M. Kasi, Kristen K. Ciombor, David L. Bajor, Tanios S. Bekaii-Saab, Olumide Gbolahan, Patrick Boland, Daniel Berg, Timothy Goggins, Anwar Saeed, Howard Burris, Johanna Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel Catenacci, Jun Gong, Ignacio Garrido-Laguna, Gene Finley, Benjamin Weinberg, Anthony Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher Chen, James Ford, Madappa Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer Shao
Publikováno v:
The Lancet Oncology. 24:496-508
Autor:
Leah L. Dietrich, Varsha Shah, Robert Hegeman, Kari B. Wisinski, Rubina Qamar, KyungMann Kim, Patrick Mansky, Mark E. Burkard, SarahMaria Donohue, Anne M. Traynor, Uchenna O. Njiaju, Amy L. Stella, Amye J. Tevaarwerk, Timothy Goggins
Publikováno v:
Clinical Breast Cancer. 14:205-211
Adjuvant therapy for breast cancer can be improved by increasing dose density. We tested the feasibility of delivering dose-dense docetaxel-cyclophosphamide (TC) in a single-arm phase II trial of 42 patients via the Wisconsin Oncology Network. Treatm
Autor:
Timothy Goggins
Publikováno v:
Oncology Times. 39:1-8
Autor:
Kyle D. Holen, Kurt R. Oettel, Timothy Goggins, Hilary R. Hernan, Anne M. Traynor, Sam J. Lubner, Emily Robinson, William R. Schelman, Daniel Mulkerin, Dustin A. Deming, David Groteluschen, Noelle K. LoConte
Publikováno v:
Investigational new drugs. 31(4)
Chemotherapy has yielded minimal clinical benefit in pancreatic and biliary tract cancer. A high-dose, short course capecitabine schedule with oxaliplatin, has shown some efficacy with a lower incidence of palmar-plantar erythrodysesthesia. Achieving